(HOMI) Home Invest Belgium - Sifi - Ratings and Ratios

Home Invest Belgium S.A. is a prominent real estate investment trust (REIT) in Belgium, specializing in residential properties. With a portfolio comprising 992 rental units and approximately 111,091 square meters of rentable space as of December 31, 2008, the company has established itself as a key player in the Belgian residential real estate market. Founded in 1980 and headquartered in Brussels, Home Invest Belgium S.A. has a long-standing history of providing stable returns through its diversified portfolio of properties. The company, formerly known as Home Invest, adopted its current name in May 1999 to reflect its strategic focus on the Belgian market. Its shares are listed on the Euronext Brussels under the ticker symbol HOMI, classified under the Residential REITs sub-industry.

The company’s operations are centered around the acquisition, management, and rental of residential properties, with a focus on maintaining a balanced portfolio across key regions in Belgium. Home Invest Belgium S.A. emphasizes long-term value creation through strategic property investments, active asset management, and a commitment to sustainability. The company’s website, accessible at https://www.homeinvestbelgium.be, provides detailed information on its portfolio, financial performance, and corporate governance.

From a technical perspective, HOMI shares are currently trading at 18.32 euros, with a 20-day average volume of 9,269. The stock’s short-term momentum is reflected in its SMA 20 of 18.18, while its SMA 50 and SMA 200 are 17.59 and 17.55, respectively, indicating a slight upward trend in the medium term. The ATR of 0.39 suggests moderate price volatility, which may present opportunities for short-term traders.

On the fundamental side, Home Invest Belgium S.A. has a market capitalization of 361.53 million euros, with a trailing P/E ratio of 6.15 and a forward P/E of 29.41, signaling expectations of future earnings growth. The price-to-book (P/B) ratio of 0.59 indicates that the stock may be undervalued relative to its book value, while the price-to-sales (P/S) ratio of 9.53 reflects a premium valuation based on revenue. The return on equity (RoE) of 12.73% highlights the company’s ability to generate profits from shareholders’ equity.

Three-Month Forecast: Based on the convergence of technical and fundamental data, HOMI is expected to experience a period of consolidation in the short term. The stock’s price is likely to oscillate between 17.50 and 18.50 euros, influenced by its SMA 20 and SMA 50 levels. The relatively low ATR of 0.39 suggests that volatility will remain contained, making the stock attractive to risk-averse investors. Fundamentally, the company’s strong RoE and undervalued P/B ratio could drive incremental buying interest, potentially pushing the stock towards its SMA 200 level of 17.55 by the end of the forecast period. However, the high P/S ratio may act as a resistance level, capping significant upside momentum in the near term.